As Diabetes Explodes, Big Pharma Is Gearing Up
by Melly Alazraki on Jan.27, 2011, under Towing
Diabetes is a growing global scourge, but for Big Pharma it’s more of a lifesaver — and many drugmakers are cranking up their research efforts. After all, many existing drugs will soon be losing their patents, and diabetes could be a $55 billion market by 2019.
Continue reading As Diabetes Explodes, Big Pharma Is Gearing Up
As Diabetes Explodes, Big Pharma Is Gearing Up originally appeared on DailyFinance on Thu, 27 Jan 2011 18:00:00.
Filed Under: Investing, Health Care, Bristol-Myers Squibb, Sanofi Aventis, Merck, GlaxoSmithKline, Eli Lilly, Astrazeneca



